Publications 2005

  1. Haduch, A.; Ogorka, T.; Boksa, J.; Daniel, W. A. Interactions between neuroleptics and CYP2C6 in rat liver in vitro and ex vivo study. Pharmacol. Rep. 2005, 57, 872-877 (http://www.ncbi.nlm.nih.gov/pubmed/16382211).
  2. Iskra-Jopa, J.; Golembiowska, K.; Dziubina, A.; Cybulski, M.; Duszynska, B.; Chilmonczyk, Z. In-vivo effects of the 1,2,4-piperazine derivatives MM5 and MC1, putative 5-HT agonists, on dopamine and serotonin release in rat prefrontal cortex. J. Pharm. Pharmacol. 2005, 57, 205-211 (http://www.ncbi.nlm.nih.gov/pubmed/15720784).
  3. Obniska, J.; Kolaczkowski, M.; Charakchieva-Minol, S.; Nedza, K.; Dybala, M.; Bojarski, A. J. Synthesis, anticonvulsant properties and 5-HT(1A)/5-HT(2A) receptor affinity of new N-[(4-arylpiperazin-1-yl)-propyl]-2-aza-spiro[4.4]nonane and [4.5]decane-1,3-dione derivatives. Pharmacol. Rep. 2005, 57, 336-344 (http://www.ncbi.nlm.nih.gov/pubmed/15985716).
  4. Kolaczkowski, M.; Zajdel, P.; Fhid, O.; Duszynska, B.; Tatarczynska, E.; Pawlowski, M. Synthesis and 5-HT(1A)/5-HT(2A) activity of some butyl analogs in the group of phenylpiperazine alkyl pyrimido[2,1-f] theophyllines. Pharmacol. Rep. 2005, 57, 229-235 (http://www.ncbi.nlm.nih.gov/pubmed/15886422).
  5. Byrtus, H.; Pawlowski, M.; Czopek, A.; Bojarski, A. J.; Duszynska, B.; Nowak, G.; Klodzinska, A.; Tatarczynska, E.; Wesolowska, A.; Chojnacka-Wojcik, E. Synthesis and 5-HT(1A), 5-HT(2A) receptor activity of new beta-tetralonohydantoins. Eur. J. Med. Chem. 2005, 40, 820-829 (http://www.ncbi.nlm.nih.gov/pubmed/16122584).
  6. Zajdel, P.; Subra, G.; Bojarski, A. J.; Duszynska, B.; Pawlowski, M.; Martinez, J. Parallel solid-phase synthesis and characterization of new sulfonamide and carboxamide proline derivatives as potential CNS agents. Bioorg. Med. Chem. 2005, 13, 3029-3035 (http://www.ncbi.nlm.nih.gov/pubmed/15781412).
  7. Bojarski, A. J.; Paluchowska, M. H.; Duszyńska, B.; Kłodzińska, A.; Tatarczyńska, E.; Chojnacka-Wójcik, E. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), α1-adrenergic and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics. Bioorg. Med. Chem. 2005, 13, 2293-3303 (http://www.ncbi.nlm.nih.gov/pubmed/15727878).
  8. Paluchowska, M. H.; Bugno, R.; Bojarski, A. J.; Charakchieva-Minol, S.; Duszyńska, B.; Tatarczyńska, E.; Kłodzinska, A.; Stachowicz, K.; Chojnacka-Wójcik, E. Novel, flexible, and conformationally defined analogs of gepirone: synthesis and 5-HT1A, 5-HT2A, and D2 receptor activity. Bioorg. Med. Chem. 2005, 13, 1195-1200 (http://www.ncbi.nlm.nih.gov/pubmed/15670928).